• Bicara Therapeutics (NASDAQ:BCAX) Given "Overweight" Rating at Cantor Fitzgerald

    Source: Buzz FX / 14 Mar 2025 11:46:17   America/Chicago


    Bicara Therapeutics (NASDAQ:BCAX) Given "Overweight" Rating at Cantor Fitzgerald Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads Bicara Therapeutics ( NASDAQ:BCAX - Get Free Report ) 's stock had its "overwei
    Read more...
Share on,